IOVANCE BIOTHERAPEUTICS (IOVA) CCO RSUs vest; shares withheld for taxes
Rhea-AI Filing Summary
IOVANCE BIOTHERAPEUTICS, INC. reported that Chief Commercial Officer Kirby Daniel Gordon had 10,001 Restricted Stock Units vest and convert into an equal number of common shares on August 10, 2026. Of these, 2,436 shares were delivered or withheld at $6.40 per share to satisfy mandatory tax withholding, which was not an open-market sale. Following the vesting, Gordon held 60,003 RSUs from the February 10, 2025 grant, with the remaining units scheduled to vest in equal quarterly installments.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 7,565 shares
Net Buy
3 txns
Insider
Kirby Daniel Gordon
Role
Chief Commercial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F4, F5, F6 | 10,001 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 10,001 | $0.00 | $0.00 |
| Tax Withholding | Common Stock F2, F3 | 2,436 | $6.40 | $16K |
Holdings After Transaction:
Restricted Stock Units — 60,003 shares (Direct);
Common Stock — 154,511 shares (Direct)
Footnotes (6)
- F1. Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
- F2. Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
- F3. Represents the common stock remaining after deducting the common stock withheld for taxes.
- F4. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F5. The remaining RSUs will vest in equal quarterly installments.
- F6. Such aggregate number reflects the remainder of such RSUs granted on February 10, 2025, but does not include any other RSUs held by such Reporting Person.
Key Figures
RSUs vested: 10,001 units
Shares withheld for taxes: 2,436 shares
Withholding price: $6.40 per share
+2 more
5 metrics
RSUs vested
10,001 units
Restricted Stock Units vested and converted into common stock on August 10, 2026
Shares withheld for taxes
2,436 shares
Common shares delivered or withheld to satisfy mandatory tax withholding upon RSU vesting
Withholding price
$6.40 per share
Price used for shares delivered or withheld for tax liability
Remaining RSUs from 2025 grant
60,003 units
RSUs remaining from February 10, 2025 grant after current vesting event
Exercise/vesting shares
10,001 shares
Common stock received upon RSU vesting on August 10, 2026
Key Terms
Restricted Stock Units, mandatory tax withholding requirements, contingent right, vesting in equal quarterly installments
4 terms
Restricted Stock Units financial
"Represents such shares underlying the restricted stock units ("RSUs") which vested"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
mandatory tax withholding requirements financial
"shares withheld by the Issuer to satisfy the mandatory tax withholding requirements"
contingent right financial
"Each RSU represents a contingent right to receive one share"
vesting in equal quarterly installments financial
"The remaining RSUs will vest in equal quarterly installments"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did IOVANCE BIOTHERAPEUTICS (IOVA) report for Kirby Daniel Gordon?
IOVANCE BIOTHERAPEUTICS reported that Chief Commercial Officer Kirby Daniel Gordon had 10,001 RSUs vest into common stock on August 10, 2026. These RSUs converted 1-for-1 into common shares as part of his equity compensation.
What is the resulting RSU position for Kirby Daniel Gordon at IOVANCE (IOVA)?
After the reported vesting, Kirby Daniel Gordon held 60,003 RSUs from the February 10, 2025 grant. This figure reflects the remaining units from that grant only and excludes any other RSUs he may hold.
Did the IOVA Form 4 report an open-market stock sale by Kirby Daniel Gordon?
The Form 4 did not report any open-market stock sale by Kirby Daniel Gordon. The 2,436 shares disposed were expressly described as shares withheld by the issuer solely to satisfy mandatory tax withholding on vested RSUs.
What does each RSU reported by IOVANCE BIOTHERAPEUTICS (IOVA) represent?
Each RSU reported for Kirby Daniel Gordon represents a contingent right to receive one share of IOVANCE BIOTHERAPEUTICS common stock. As RSUs vest, they convert on a 1-for-1 basis into common shares, subject to applicable tax withholding.
How will the remaining RSUs for Kirby Daniel Gordon at IOVA vest over time?
The remaining RSUs from the February 10, 2025 grant to Kirby Daniel Gordon will vest in equal quarterly installments. This schedule gradually delivers common shares over time, contingent on continued service and subject to tax withholding at each vesting.